Long-term care of the patient with the atrial defibrillator

American Heart Journal

Volumn 147, Issue 2, 2004, Pages 210-217

  Mitchell, Andrew Robert John ^a,b,c   Spurrell, Philip Anthony Roworth ^a,b   Boodhoo, Lana Elizabeth ^a,b   Sulke, Neil ^a,b  

^a Eastbourne General Hospital ^*

^b EASTBOURNE DISTRICT GENERAL HOSPITAL   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADAPTATION; CARDIOVERSION; DEFIBRILLATION; DEFIBRILLATOR; DEVICE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOME CARE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IMPLANT; LONG TERM CARE; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; REVIEW; TREATMENT PLANNING;

EID: 0842347619     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2003.07.017     Document Type: Article

References (43)

1. Stewart S, Hart CL, Hole DJ, et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart 2001;86:516-21.
2. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001;285:2370-5.
3. The AFFIRM investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
4. Mitchell AR. Atrial fibrillation in the new millennium-the role of pacemaker and defibrillator therapy. Med Sci Monitor 2002;8: RA233-9.
5. Hindricks G, Kottkamp H. Potential benefits, risks, and complications of catheter ablation of atrial fibrillation: more questions than answers. J Cardiovasc Electrophysiol 2002;13:768-9.
6. Camm AJ. The atrial fibrillation therapy study. Pacing Clin Electrophysiol 2002;24:554.
7. Daoud EG, Timmermans C, Fellows C, et al. Initial clinical experience with ambulatory use of an implantable atrial defibrillator for conversion of atrial fibrillation. Metrix Investigators. Circulation 2000;102:1407-13.
8. Gold MR, Sulke N, Schwartzman D, et al. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2001;12:1247-53.
9. Gillis AM, Unterberg-Buchwald C, Schmidinger H, et al. Safety and efficacy of advanced atrial pacing therapies far atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol 2002;40:1653-9.
10. Boriani G, Wollmann C, Biffi M, et al. Evaluation of a dual chamber ICD for the treatment of atrial and ventricular arrhythmias. Europace 2002;3:A41.
11. Seidl K, Hauer B, Kirca M, et al. Importance of preimplantation procedures in candidates for an implantable atrial defibrillator. J Cardiovasc Electrophysiol 1998;9:S127-31.
12. Steinhaus DM, Cardinal DS, Mongean L, et al. Internal defibrillation: pain perception of low energy shocks. Pacing Clin Electrophysiol 2002;25:1090-3.
13. Mitchell AR, Spurrell PA, Boodhoo L, et al. Psychosocial aspects of patient-activated atrial defibrillation. J Cardiovasc Electrophysiol 2003;14:1-5.
14. Mitchell AR, Spurrell PA, Kamalvand K, et al. What is the optimal electrode configuration for atrial defibrillators in man? Europace 2002;4:41-4.
15. Mitchell AR, Spurrell PA, Ahmet H, et al. Echocardiographic changes and predictors of arrhythmia recurrence after long-term use of the atrial defibrillator. Int J Cardiol 2003;89:25-31.
16. Spurrell PA, Mitchell AR, Kamalvand K, et al. The impact of atrial defibrillators on the natural history of persistent atrial fibrillation: does sinus rhythm beget more sinus rhythm? J Am Coll Cardiol 2001;37:95A.
17. Schwartzman D, Hoyt RH, Sulke N, et al. Patterns of coumadin use and cerebrovascular accident in patients implanted with the Jewel AF device. Pacing Clin Electrophysiol 2001;24:639.
18. Lok NS, Lau CP, Tse HF, et al. Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system. J Am Coll Cardiol 1997;30:1324-30.
19. Murgatrayd FD, Slade AK, Sopher SM, et al. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol 1995;25:1347-53.
20. Kidwai BJ, Allen JD, Harbinson MT, et al. Waveform optimization for internal atrial defibrillation: effects of waveform rounding, phase duration, and voltage swing. Pacing Clin Electrophysiol 2001;24:1198-207.
21. Boriani G, Biffi M, Bronzetti G, et al. Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation. Am J Cardiol 1998;81:241-4.
22. Timmermans C, Nabar A, Rodriguez LM, et al. Use of sedation during cardioversion with the implantable atrial defibrillator. Circulation 1999;100:1499-501.
23. Haffajee CI, Chaudhry GM, Casavant D, et al. Efficacy and tolerability of automatic nighttime atrial fibrillation shocks in patients with permanent internal atrial defibrillators. Am J Cardiol 2002; 89:875-8.
24. Ujhelyi MR, Sears SF Jr, Burns JL, et al. Characterization of atrial shock pain from implantable atrial defibrillator: patient activated vs. automatic nighttime atrial shocks. Pacing Clin Electrophysiol 2002;24:712.
25. Timmermans C, Rodriguez LM, Ayers GM, et al. Effect of butorphanol tartrate on shock-related discomfort during internal atrial defibrillation. Circulation 1999;99:1837-42.
26. Mitchell AR, Spurrell PA, Sulke N. The atrial defibrillator sedation assessment study (ADSAS). Int J Cardiol 2004 (in press).
27. Swerdlow CD, Schsls W, Dijkman B, et al. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. Far the Worldwide Jewel AF Investigators. Circulation 2000;101:878-85.
28. Mitchell AR, Spurrell PA, Cheatle L, et al. Effect of atrial antitachycardio pacing treatments in patients with an atrial defibrillator: randomised study comparing subthreshold and nominal pacing outputs. Heart 2002;87:433-7.
29. Lau CP, Tse HF. Early reinitiation of atrial fibrillation after electrical defibrillation: a new electrophysiological phenomenon. Pacing Clin Electrophysiol 2001;24:1581-4.
30. Swerdlow CD, Schwartzman D, Hoyt R, et al. Determinants of first-shock success for atrial implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2002;13:347-54.
31. Schwartzman D, Musley SK, Swerdlow C, et al. Early recurrence of atrial fibrillation after ambulatory shock conversion. J Am Coll Cardiol 2002;40:93-9.
32. Dijkman B, Wellens HJ. Merits and limitations of the mode switching rate stabilization pacing algorithms in the implantable cardioverter defibrillator. J Interv Cord Electrophysiol 2001;5: 309-18.
33. Mitchell AR, Spurrell PA, Sulke N. Atrial fibrillation storms. Int J Clin Pract 2003;57:349-50.
34. Shehadeh LA, Liebovitch LS, Wood MA. Temporal patterns of atrial arrhythmia recurrences in patients with implantable defibrillators: implications for assessing antiarrhythmic therapies. J Cardiovasc Electrophysiol 2002;13:303-9.
35. Mitchell AR, Spurrell PA, Kamalvand K, et al. The circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation. Am Heart J 2003;146:902-7.
36. Behrens S, Ehlers C, Bruggemann T, et al. Modification of the circadian pattern of ventricular tachyarrhythmias by beta-blocker therapy. Clin Cardiol 1997;20:253-7.
37. Page RL, Wilkinson WE, Clair WK, et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994; 89:224-7.
38. Sears SF Jr, Conti JB. Quality of life and psychological functioning of ICD patients. Heart 2002;87:488-93.
39. Weretka S, Becker R, Hilbel T, et al. Far-field R wave oversensing in a dual chamber arrhythmia management device: predisposing factors and practical implications. Pacing Clin Electrophysiol 2001;24:1240-6.
40. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardiol infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
41. Sears SF, Todaro JF, Urizar G, et al. Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care providers. Pacing Clin Electrophysiol 2000;23:939-45.
42. Davis LL, Vitale KA, Irmiere CA, et al. Psychosocial adaptation of patients in a long-term pacemaker trial. Pacing Clin Electrophysiol 2002;24:551.
43. Sears SF, Burns JL, Schwartzman D, et al. Do patients accept implantable atrial device therapy? Pacing Clin Electrophysiol 2002; 25:596.